Lakshminrusimha, S
Konduri, G G
Steinhorn, R H
Article History
Received: 15 October 2015
Revised: 10 February 2016
Accepted: 16 February 2016
First Online: 26 May 2016
Competing interests
: SL, GGK and RHS received honoraria for their participation in a roundtable meeting supported by a grant from Mallinckrodt Pharmaceuticals, formerly Ikaria. SL was a member of the speaker’s bureau for Ikaria from June 2010 to October 2014 and has received grant support from the American Academy of Pediatrics and Canadian Pediatric Society. GGK has received consulting fees from Boston Health Economics and Actelion Clinical Research and lecture fees from Quintiles. RHS has received research grant support from Pfizer. NIH Grants: 5R01HD072929-03 (to SL); 5R01HL057268-11 (to GGK); 5R01HL054705-13 (to RHS).
Free to read: This content has been made available to all.